| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2011) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | V08CA09 |
| UNII: | 1BJ477IO2L |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C18H31GdN4O9 |
| Molecular Weight | 604.72 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Diagnostic agent | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Heart Failure | 1 | D006333 | ClinicalTrials |
| Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
Related Entries
MCS
Side Effects from Label
Side Effects (PT)
| Side effects | Relative Frequency (%) | Labels | |
|---|---|---|---|
| Nervous system disorders Headache | 1.1 | ||
| Nervous system disorders Headache | 0.9 | ||
| Gastrointestinal disorders Nausea | 0.9 | ||
| Gastrointestinal disorders Nausea | 0.5 | ||
| General disorders and administration site conditions Injection site pain | 0.4 | ||
| Skin and subcutaneous tissue disorders Dermatitis | 0.3 | ||
| Cardiac disorders Dizziness | 0.3 | ||
| Cardiac disorders Dyspnoea | 0.3 | ||
| Skin and subcutaneous tissue disorders Rash | 0.3 |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 770691-21-9 |
| ChEMBL | CHEMBL2218860 |
| FDA SRS | 1BJ477IO2L |
| PubChem | 6102852 |
CONTENTS